KMS Medisurgi Limited (BOM:540468)
India · Delayed Price · Currency is INR 132.80
+6.30 (4.98%)
At close: May 13, 2026
KMS Medisurgi Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 122.09 | 122.09 | 139.39 | 138.85 | 110.27 | 103.17 |
Revenue Growth | -4.18% | -12.41% | 0.39% | 25.91% | 6.88% | 37.38% |
Gross Profit Gross Profit Growth | 33.87 | 33.87 | 31.71 | 30.15 | 30.27 | 24.25 |
Operating Income Operating Income Growth | 4.26 | 4.26 | 6.73 | 5.32 | 6.43 | 2.35 |
Net Income Net Income Growth | 2.46 | 2.46 | 4.4 | 4.54 | 5.73 | 2.15 |
Earnings Per Share EPS Growth | 0.74 | 0.74 | 1.33 | 1.38 | 1.74 | 0.65 |
EPS Growth | -58.57% | -44.36% | -3.28% | -20.79% | 166.22% | 75.10% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 11.05 | 11.05 | 4.67 | 4.19 | 1.9 | 4.03 |
Total Debt Total Debt Growth | 7.73 | 7.73 | 9.13 | 5.4 | 9.91 | 9.91 |
Net Cash (Debt) Net Cash Growth | 3.31 | 3.31 | -4.46 | -1.21 | -8 | -5.88 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.00 | 1.00 | -1.35 | -0.37 | -2.42 | -1.78 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 15.13 | 15.13 | 7.37 | 12.09 | 4.58 | -0.68 |
Capital Expenditures CapEx Growth | -17.2 | -17.2 | -9.7 | -5.33 | -6.61 | -1.18 |
Free Cash Flow Free Cash Flow Growth | -2.07 | -2.07 | -2.33 | 6.75 | -2.03 | -1.86 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 27.74% | 27.74% | 22.75% | 21.71% | 27.45% | 23.51% |
Operating Margin | 3.49% | 3.49% | 4.83% | 3.83% | 5.83% | 2.28% |
Pretax Margin | 2.71% | 2.71% | 4.38% | 4.35% | 5.97% | 2.76% |
Profit Margin | 2.01% | 2.01% | 3.16% | 3.27% | 5.20% | 2.09% |
FCF Margin | -1.69% | -1.69% | -1.67% | 4.86% | -1.84% | -1.81% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.050 | - | 0.050 | 0.050 | 0.050 | 0.050 |
Dividend Per Share Growth | 0% | - | 0% | 0% | 0% | 0% |
Dividend Yield | 0.04% | - | 0.04% | 0.04% | 0.07% | 0.15% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 179.46 | 170.04 | 93.79 | 88.65 | 40.12 | 52.83 |
P/FCF Ratio | - | - | - | 59.57 | - | - |
PS Ratio | 3.59 | 3.42 | 2.96 | 2.90 | 2.08 | 1.10 |